지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.8
- 수록면
- 231 - 239 (9page)
이용수
초록· 키워드
오류제보하기
Toxoplasma gondii is an intracellular parasitic organism affecting all warm-blooded vertebrates. Due to the unavailability of commercialized human T. gondii vaccine, many studies have been reported investigating the protective efficacy of pre-clinical T. gondii vaccines expressing diverse antigens. Careful antigen selection and implementing multifarious immunization strategies could enhance protection against toxoplasmosis in animal models. Although none of the available vaccines could remove the tissue-dwelling parasites from the host organism, findings from these pre-clinical toxoplasmosis vaccine studies highlighted their developmental potential and provided insights into rational vaccine design. We herein explored the progress of T. gondii vaccine development using DNA, protein subunit, and virus-like particle vaccine platforms. Specifically, we summarized the findings from the pre-clinical toxoplasmosis vaccine studies involving T. gondii challenge infection in mice published in the past 5 years.
목차
Abstract
Introduction
What is a vaccine and how do they work?
DNA vaccines
Protein subunit vaccines
Virus-like Particle (VLP) vaccines
Conclusion
References
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Rhoptry antigens as Toxoplasma gondii vaccine target
Clinical and Experimental Vaccine Research
2019 .01
-
Recent progress in microneme-based vaccines development against Toxoplasma gondii
Clinical and Experimental Vaccine Research
2018 .01
-
Virus-like Particle Vaccine Containing Toxoplasma gondii Rhoptry Protein 13 Induces Protection against T. gondii ME49 Infection in Mice
Parasites, Hosts and Diseases
2019 .10
-
Immunoinformatic analysis of immunogenic B- and T-cell epitopes of MIC4 protein to designing a vaccine candidate against Toxoplasma gondii through an in-silico approach
Clinical and Experimental Vaccine Research
2021 .01
-
Immune Responses Induced by HSP60 DNA Vaccine against Toxoplasma gondii Infection in Kunming Mice
Parasites, Hosts and Diseases
2018 .06
-
Should the COVID-19 Vaccine be Administered Simultaneously with Other Vaccines?
Infection and Chemotherapy
2021 .09
-
Evaluation of Protective Immunity of Peptide Vaccines Composed of a 15-mer N-terminal Matrix Protein 2 and a Helper T-Cell Epitope Derived from Influenza A Virus
Immune Network
2019 .08
-
Parenteral, non-live rotavirus vaccine: recent history and future perspective
Clinical and Experimental Vaccine Research
2021 .09
-
Inhibitory Effect of WK03 extract on Proinflammatory Cytokines Production in infection of Toxoplasma (T.) gondii
한국실험동물학회 학술발표대회 논문집
2015 .08
-
Exploring the experience of developing COVID-19 vaccines in Iran
Clinical and Experimental Vaccine Research
2023 .01
-
Review of COVID-19 Vaccines and Their Evidence in Older Adults
Annals of geriatric medicine and research
2021 .01
-
Vaccines in the United States: a systematic review on history of evolution, regulations, licensing, and future challenges
Clinical and Experimental Vaccine Research
2020 .01
-
Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic
Immune Network
2021 .02
-
Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development
Clinical and Experimental Vaccine Research
2024 .04
-
DNA Vaccines Encoding Toxoplasma gondii Cathepsin C1 Induce Protection against Toxoplasmosis in Mice
Parasites, Hosts and Diseases
2017 .10
-
Therapeutic Vaccines and Nucleic Acid Drugs for Cardiovascular Disease
지질·동맥경화학회지
2024 .09
-
The Characteristics of RNA Vaccine
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2016 .09
-
Detection of Toxoplasma gondii Infections using Virus-Like Particles Displaying T. gondii ROP4 Antigen
Parasites, Hosts and Diseases
2021 .12
-
Advancements in Cancer Immunotherapy: The Evolution and Future of mRNA and DNA Vaccine Technologies
대한의생명과학회지
2025 .03
-
Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection
Parasites, Hosts and Diseases
2018 .10
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-151-24-02-088215485